Drug Development Approaches for Poorly Soluble Compounds
Language: English
Published by Wiley-VCH Gmbh Aug 2026, 2026
- Hardcover
- New
Condition: New
£ 145.79
Quantity: 1 available
Add to basketItem description from seller
Neuware -Ten proven strategies to overcome solubility challenges in drug development Poor water solubility prevents drug candidates from reaching their therapeutic targets, causing promising compounds to fail during development. Drug Development Approaches for Poorly Soluble Compounds presents ten distinct strategies for overcoming this challenge, from altering drug structure and creating prodrugs to formulation techniques using nanosuspensions, microemulsions, micelles, co-crystals, and co-solvents. Each approach includes case studies from current pharmaceutical industry projects. This reference covers strategies applicable to virtually every drug type, regardless of molecular size or chemical composition. Beyond formulation science, the book addresses solubility-related commercial and regulatory considerations essential for bringing drugs to market. Special attention is given to animal study requirements for poorly soluble compounds. Each chapter demonstrates approaches through examples from recent pharmaceutical development projects across small and large companies. Readers will also find: - Detailed explanations of ten formulation strategies including nanosuspensions, microemulsions, micelles, co-crystals, and co-solvent approaches for enhancing drug solubility - Practical case studies drawn from recent pharmaceutical industry drug development projects demonstrating real-world applications of each solubility enhancement strategy - Guidance on regulatory considerations specific to poorly soluble compounds, helping developers navigate approval pathways more efficiently throughout the development process - Coverage of special requirements for conducting animal studies with compounds that exhibit poor solubility in biological fluids - Commercial considerations for solubility enhancement strategies that reduce required drug substance amounts, lowering costs and minimizing potential side effects Designed for medicinal chemists, pharmaceutical chemists, pharmacologists, and pharmaceutical industry professionals, this book ensures no drug candidate fails due to solubility challenges. The strategies presented here apply across compound types and development stages, providing practitioners with proven solutions for this common development obstacle.…
Seller Inventory # 9783527354788
- Title
- Drug Development Approaches for Poorly Soluble Compounds
- Author
- Yogeshwar Bachhav
- Publisher
- Wiley-VCH Gmbh Aug 2026
- Publication year
- 2026
- Condition
- Neu
- Binding
- Buch
- Language
- English
- ISBN 10
- 3527354786
- ISBN 13
- 9783527354788
- Item weight
- 1,030 grams
- Dimensions
- 245x172x30 mm
Ten proven strategies to overcome solubility challenges in drug development
Poor water solubility prevents drug candidates from reaching their therapeutic targets, causing promising compounds to fail during development. Drug Development Approaches for Poorly Soluble Compounds presents ten distinct strategies for overcoming this challenge, from altering drug structure and creating prodrugs to formulation techniques using nanosuspensions, microemulsions, micelles, co-crystals, and co-solvents. Each approach includes case studies from current pharmaceutical industry projects.
This reference covers strategies applicable to virtually every drug type, regardless of molecular size or chemical composition. Beyond formulation science, the book addresses solubility-related commercial and regulatory considerations essential for bringing drugs to market. Special attention is given to animal study requirements for poorly soluble compounds. Each chapter demonstrates approaches through examples from recent pharmaceutical development projects across small and large companies.
Readers will also find:
- Detailed explanations of ten formulation strategies including nanosuspensions, microemulsions, micelles, co-crystals, and co-solvent approaches for enhancing drug solubility
- Practical case studies drawn from recent pharmaceutical industry drug development projects demonstrating real-world applications of each solubility enhancement strategy
- Guidance on regulatory considerations specific to poorly soluble compounds, helping developers navigate approval pathways more efficiently throughout the development process
- Coverage of special requirements for conducting animal studies with compounds that exhibit poor solubility in biological fluids
- Commercial considerations for solubility enhancement strategies that reduce required drug substance amounts, lowering costs and minimizing potential side effects
Designed for medicinal chemists, pharmaceutical chemists, pharmacologists, and pharmaceutical industry professionals, this book ensures no drug candidate fails due to solubility challenges. The strategies presented here apply across compound types and development stages, providing practitioners with proven solutions for this common development obstacle.
"Synopsis" may belong to another edition of this title.
About the Author
Dr. Yogeshwar Bachhav is a distinguished pharmaceutical professional with over 19 years of experience in drug development, spanning R&D, CMC, regulatory strategy, and business development. From his previous experiences working at Pantec Biosolutions AG (Liechtenstein), DebioPharm (Switzerland), AiCuris (Germany) and as a founder and Director of Adex Pharma, to date he has successfully contributed to the CMC development of several drug candidates from discovery to clinical and commercial phases. Currently, he also serves as an Independent Consultant at AiCuris Anti-infective Cures AG, Germany, leading formulation design, outsourcing, and regulatory documentation (IMPD/IND, ANDA) across global markets. Dr. Bachhav holds M.Pharm in Pharmaceutical Chemistry and PhD in Pharmaceutics from ICT (Mumbai), an LL.B from the University of Mumbai, and a Global MBA from the University of Western Australia, along with an Advanced Business Management certification from IIM Kozhikode. With 19 peer-reviewed publications, 7 international patents, more than 50 invited talks globally and as an editor of 3 books, Dr. Bachhav continues to advance pharmaceutical innovation through his deep scientific expertise and strategic leadership.
"About the title" may belong to another edition of this title.
Shipping rates from Germany to U.S.A.
| Item | 9 to 30 business days | 8 to 14 business days |
|---|---|---|
| First item | £ 21.73 | £ 27.60 |
Payment methods
- Bank Wire Transfer
- Cash
- Cash on Delivery
- Check
- Paypal
Store description
Die Schreibwaren sind im Büro, in der Schule und Zuhause allgegenwärtig und auch im Computerzeitalter nicht aus dem Alltag wegzudenken. Schreibwaren Wegmann ist Ihr Online Shop für Bürobedarf und Schulbedarf, der das ganze Sortiment an Büromaterial und Schulsachen zu günstigen Preisen online zu kaufen bietet. In unserem ständig wachsendem Angebot im Online Shop führen wir derzeit viele tausend Büroartikel, alles rund um die Schule, Bürotechnik, Büroeinrichtung bis hin zu ausgefallenen Geschenkartikeln und Postkarten, originell oder regional aus der Region Bayerischer Wald, Böhmerwald, Arberland und Zwiesel. Schreibwaren Wegmann ist Ihr Schreibwarengeschäft. Besuchen Sie uns gerne auch persönlich in unserem Schreibwarenladen in Zwiesel am Stadtplatz 6. Wir heißen Sie herzlich willkommen. Unsere Öffnungszeiten im Schreibwarengeschäft: Montag - Freitag : 07.30 - 19.00 Uhr, Samstag 07.30 - 16.00 Uhr. Und natürlich rund um die Uhr, 24/7, im Schreibwaren Online Shop.…
Seller's business information
Metz Wegmann GmbH
Waldbahnstraße 94
Zwiesel, Germany 94227
Terms of sale
Metz Wegmann GmbH
Waldbahnstr. 94
94227 Zwiesel
Deutschland
Tel.: 09922609490
Fax: 09922609491
E-Mail: info@schreibwaren-wegmann.de
Registergericht: Amtsgericht Deggendorf
Registernummer: HRB 5721
Geschäftsführer: Janos Metz
Umsatzsteuer-Identifikationsnummer: DE364194228
Verantwortliche/r i.S.d. § 18 Abs. 2 MStV:
Janos Metz, Stadtplatz 6, 94227 Zwiesel
Zuständige Aufsichtsbehörde für das Angebot audiovisueller Mediendienste:
Bayerische Landeszentrale für neue Medien (BLM), Heinrich-Lübke-Straße 27, 81737 München, Deutschland
Wir sind zur Teilnahme an einem Streitbeilegungsverfahren vor einer Verbraucherschlichtungsstelle weder verpflichtet noch bereit.
Betriebsstätte:
Stadtplatz 6
94227 Zwiesel
Deutschland
Right of withdrawal
If you are a consumer you can withdraw from the contract in accordance with the following. Consumer means any natural person who is acting for purposes which are outside his trade, business, craft or profession.
Information regarding the right of withdrawal
Statutory right to withdraw
You have the right to withdraw from this contract within 14 days without giving any reason.
The withdrawal period will expire after 14 days from the day on which you acquire, or a third party other than the carrier and indicated by you acquires, physical possession of the last good or the last lot or piece.
To exercise the right of withdrawal, electronically fill in and submit a clear statement on our website, under "My Purchases" in "My Account". We will communicate to you an acknowledgement of receipt of such a withdrawal on a durable medium (e.g. by e-mail) without delay.
To meet the withdrawal deadline, it is sufficient for you to send your communication concerning your exercise of the right of withdrawal before the withdrawal period has expired.
Effects of withdrawal
If you withdraw from this contract, we will reimburse to you all payments received from you, including the costs of delivery (except for the supplementary costs arising if you chose a type of delivery other than the least expensive type of standard delivery offered by us).
We may make a deduction from the reimbursement for loss in value of any goods supplied, if the loss is the result of unnecessary handling by you.
We will make the reimbursement without undue delay, and not later than 14 days after the day on which we are informed about your decision to withdraw from this contract.
We will make the reimbursement using the same means of payment as you used for the initial transaction, unless you have expressly agreed otherwise; in any event, you will not incur any fees as a result of such reimbursement.
We may withhold reimbursement until we have received the goods back, or you have supplied evidence of having sent back the goods, whichever is the earliest.
You shall send back the goods or hand them over to Wegmann1855, Zwiesel, Germany, +49 22609490, without undue delay and in any event not later than 14 days from the day on which you communicate your withdrawal from this contract to us. The deadline is met if you send back the goods before the period of 14 days has expired. You will have to bear the direct cost of returning the goods. You are only liable for any diminished value of the goods resulting from the handling other than what is necessary to establish the nature, characteristics and functioning of the goods.
Exceptions to the right of withdrawal
The right of withdrawal does not apply to:
- The delivery of newspapers, journals or magazines with the exception of subscription contracts; and
- The supply of digital content which is not supplied on a tangible medium (e.g. on a CD or DVD) if you accepted when you placed your order that we could start to deliver it, and that you could not withdraw once delivery had started.